- Home
- ALLR vs LRE Comparison
ALLR vs LRE Comparison
Compare ALLR & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- LRE
- Stock Information
- Founded
- ALLR 2004
- LRE 2001
- Country
- ALLR United States
- LRE Japan
- Employees
- ALLR N/A
- LRE N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- LRE
- Sector
- ALLR Health Care
- LRE
- Exchange
- ALLR Nasdaq
- LRE Nasdaq
- Market Cap
- ALLR 20.2M
- LRE 20.5M
- IPO Year
- ALLR N/A
- LRE 2023
- Fundamental
- Price
- ALLR $1.23
- LRE $1.52
- Analyst Decision
- ALLR Strong Buy
- LRE
- Analyst Count
- ALLR 1
- LRE 0
- Target Price
- ALLR $9.25
- LRE N/A
- AVG Volume (30 Days)
- ALLR 262.6K
- LRE 130.1K
- Earning Date
- ALLR 11-14-2025
- LRE 01-01-0001
- Dividend Yield
- ALLR N/A
- LRE N/A
- EPS Growth
- ALLR N/A
- LRE N/A
- EPS
- ALLR N/A
- LRE N/A
- Revenue
- ALLR N/A
- LRE $110,330,328.00
- Revenue This Year
- ALLR N/A
- LRE N/A
- Revenue Next Year
- ALLR N/A
- LRE N/A
- P/E Ratio
- ALLR N/A
- LRE N/A
- Revenue Growth
- ALLR N/A
- LRE 3.92
- 52 Week Low
- ALLR $0.61
- LRE $1.00
- 52 Week High
- ALLR $2.35
- LRE $2.97
- Technical
- Relative Strength Index (RSI)
- ALLR 40.99
- LRE 52.89
- Support Level
- ALLR $1.09
- LRE $1.32
- Resistance Level
- ALLR $1.45
- LRE $1.77
- Average True Range (ATR)
- ALLR 0.09
- LRE 0.16
- MACD
- ALLR -0.02
- LRE -0.01
- Stochastic Oscillator
- ALLR 37.42
- LRE 53.70
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.